KIF4A and microscopic polyangiitis: Next to anti-KIF5C (aa 743–783) and anti-KIF13A (aa 1595–1682), anti-KIF4A (aa 376–461) also passed this cutoff and showed a trend with higher prevalence in anti-MPO positive and MPA patients (p = 0.093) (Figure 3a).